Quarterly Transactions Made in I Teos Therapeutics, Inc. (ITOS)
This table provides information about the institutional ownership of I Teos Therapeutics, Inc. (ITOS). The information is specifically focused on institutions that hold shares of iTeos Therapeutics, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 2,461,089 | 2,181,427 | 4,642,516 | 807,378 | 1,307,432 | 2,114,810 | 2,527,706 | |
Q4 2021 | 2,304,147 | 1,949,177 | 4,253,324 | 2,136,173 | 225,386 | 2,361,559 | 1,891,765 | |
Q1 2022 | 6,375,758 | 3,313,499 | 9,689,257 | 6,735,625 | 368,184 | 7,103,809 | 2,585,448 | |
Q2 2022 | 5,454,904 | 1,050,544 | 6,505,448 | 3,114,225 | 2,227,446 | 5,341,671 | 1,163,777 | |
Q3 2022 | 3,401,791 | 708,937 | 4,110,728 | 3,134,960 | 33,860 | 3,168,820 | 941,908 | |
Q4 2022 | 1,397,879 | 1,662,156 | 3,060,035 | 2,778,388 | 0 | 2,778,388 | 281,647 | |
Q1 2023 | 1,669,357 | 838,759 | 2,508,116 | 1,842,204 | 467 | 1,842,671 | 665,445 | |
Q2 2023 | 2,084,271 | 837,411 | 2,921,682 | 2,665,288 | 0 | 2,665,288 | 256,394 | |
Q3 2023 | 1,570,833 | 1,688,364 | 3,259,197 | 1,520,858 | 0 | 1,520,858 | 1,738,339 | |
Q4 2023 | 3,216,855 | 6,390,201 | 9,607,056 | 3,468,020 | 0 | 3,468,020 | 6,139,036 | |
Q1 2024 | 2,987,464 | 2,140,213 | 5,127,677 | 2,194,696 | 0 | 2,194,696 | 2,932,981 | |
Q2 2024 | 4,991,534 | 6,436,546 | 11,428,080 | 4,125,820 | 0 | 4,125,820 | 7,302,260 | |
Q3 2024 | 3,180,747 | 2,991,501 | 6,172,248 | 4,976,257 | 0 | 4,976,257 | 1,195,991 |